The standard of care for allergic asthma consists of inhaled corticosteroids and short- and long-acting bronchodilators, which control asthma symptoms in the majority of patients, complemented by anti-IL4 and anti-IL5 pathway therapies [4]. Here, IL5 is linked to asthma.